Martin Carlsson Selected Research

Tolterodine Tartrate (Detrol)

10/2017	Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.
5/2011	Long-term safety, tolerability, and efficacy of fesoterodine treatment in men and women with overactive bladder symptoms.
5/2011	Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder.
5/2011	Superior efficacy of fesoterodine over tolterodine extended release with rapid onset: a prospective, head-to-head, placebo-controlled trial.
1/2010	Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
11/2008	Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
9/2008	Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms.
7/2007	The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder.
4/2007	Onset of efficacy of tolterodine extended release in patients with overactive bladder.
11/2006	Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Carlsson Research Topics

Disease

17	Overactive Urinary Bladder (Overactive Bladder) 01/2021 - 11/2006
11	Urinary Incontinence 01/2021 - 11/2006
4	Erectile Dysfunction 10/2017 - 09/2007
4	Lower Urinary Tract Symptoms 11/2008 - 11/2006
3	Constipation 02/2019 - 01/2010
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 11/2008 - 11/2006
2	Anorexia Nervosa 10/2021 - 04/2018
2	Vitamin D Deficiency 04/2018 - 11/2016
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 03/2017
2	Hypertension (High Blood Pressure) 01/2018 - 03/2017
2	Stroke (Strokes) 10/2017 - 11/2016
2	Weight Gain 04/2011 - 12/2010
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2010 - 05/2005
2	Inflammation (Inflammations) 12/2010 - 01/2008
1	Epilepsy (Aura) 01/2021
1	Neoplasms (Cancer) 10/2020
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 01/2019
1	Birth Weight (Birth Weights) 01/2019
1	IgA Deficiency 01/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019
1	Turner Syndrome (Turner's Syndrome) 01/2019
1	Amyloidosis 08/2018
1	Diabetes Mellitus 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Heart Failure 10/2017
1	Headache (Headaches) 10/2017
1	Urinary Tract Infections (Urinary Tract Infection) 10/2017
1	Spinal Cord Injuries (Spinal Cord Injury) 10/2017
1	Myocardial Infarction 10/2017
1	Osteoporosis 11/2016
1	Hip Fractures (Intertrochanteric Fractures) 11/2016
1	Frailty 11/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2016
1	Obesity 02/2016
1	Nocturia 04/2013
1	Insulin Resistance 12/2010
1	Lyme Neuroborreliosis 02/2010
1	Pulmonary Arterial Hypertension 01/2009
1	Overweight 09/2008
1	Urinary Retention 11/2006
1	Carotid Artery Diseases 05/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2005

Drug/Important Bio-Agent (IBA)

11	fesoterodine FDA Link 01/2021 - 01/2010
10	Tolterodine Tartrate (Detrol)FDA Link 10/2017 - 11/2006
5	Sildenafil Citrate (Viagra)FDA Link 10/2017 - 09/2007
4	Muscarinic AntagonistsIBA 10/2017 - 11/2006
3	Growth Hormone (Somatotropin)IBA 01/2019 - 01/2018
3	Vitamin D FDA LinkGeneric 04/2018 - 02/2016
3	Tamsulosin (Flomax)FDA LinkGeneric 11/2008 - 11/2006
1	OsteopontinIBA 10/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2019
1	AutoantibodiesIBA 01/2019
1	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	AntibodiesIBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 08/2018
1	NitratesIBA 10/2017
1	hydroxide ionIBA 11/2016
1	Cholecalciferol (Vitamin D3)FDA Link 02/2016
1	HDL CholesterolIBA 04/2011
1	AdiponectinIBA 12/2010
1	Insulin (Novolin)FDA Link 12/2010
1	ResistinIBA 12/2010
1	C-Reactive ProteinIBA 12/2010
1	Hormones (Hormone)IBA 02/2010
1	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2010
1	Pharmaceutical PreparationsIBA 07/2009
1	Glucose (Dextrose)FDA LinkGeneric 01/2008
1	Lipoproteins (Lipoprotein)IBA 01/2008
1	LipidsIBA 01/2008
1	Codon (Codons)IBA 05/2005
1	Fatty Acid-Binding ProteinsIBA 05/2005
1	Threonine (L-Threonine)FDA Link 05/2005
1	Alanine (L-Alanine)FDA Link 05/2005

Therapy/Procedure

3	Therapeutics 10/2020 - 04/2013
1	Drug Therapy (Chemotherapy) 10/2020
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2020
1	Injections 01/2019
1	Duration of Therapy 01/2018
1	Polypharmacy 01/2017
1	Long-Term Care 11/2016
1	Aftercare (After-Treatment) 02/2010